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Abstract
Borrelia burgdorferi is the causative agent of Lyme disease, the most commonly reported arthropod-borne disease in the
United States. B. burgdorferi is a highly invasive bacterium, yet lacks extracellular protease activity. In order to aid in its
dissemination, B. burgdorferi binds plasminogen, a component of the hosts’ fibrinolytic system. Plasminogen bound to the
surface of B. burgdorferi can then be activated to the protease plasmin, facilitating the bacterium’s penetration of
endothelial cell layers and degradation of extracellular matrix components. Enolases are highly conserved proteins with no
sorting sequences or lipoprotein anchor sites, yet many bacteria have enolases bound to their outer surfaces. B. burgdorferi
enolase is both a cytoplasmic and membrane associated protein. Enolases from other pathogenic bacteria are known to
bind plasminogen. We confirmed the surface localization of B. burgdorferi enolase by in situ protease degradation assay and
immunoelectron microscopy. We then demonstrated that B. burgdorferi enolase binds plasminogen in a dose-dependent
manner. Lysine residues were critical for binding of plasminogen to enolase, as the lysine analog eaminocaproic acid
significantly inhibited binding. Ionic interactions did not play a significant role in plasminogen binding by enolase, as excess
NaCl had no effects on the interaction. Plasminogen bound to recombinant enolase could be converted to active plasmin.
We conclude that B. burgdorferi enolase is a moonlighting cytoplasmic protein which also associates with the bacterial outer
surface and facilitates binding to host plasminogen.
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Introduction
Borrelia burgdorferi, the Lyme disease spirochete, causes the most
common arthropod-borne disease in the United States and many
other temperate regions of the world. Lyme disease is a significant
cause of morbidity and it continues to be a serious public health
concern [1]. Spirochetes such as B. burgdorferi are unique pathogens
in that they lack classical virulence factors such as toxins. Instead,
part of their remarkable ability to cause disease and suffering lies in
their ability to widely disseminate throughout host tissues. B.
burgdorferi lacks surface proteases that could degrade the hosts’
extracellular matrix and accelerate the spirochete’s penetration of
host tissues. However, B. burgdorferi can usurp a host protease,
plasminogen.
Plasminogen is a serine protease present in serum as an inactive
proenzyme [2]. Plasminogen is converted by tissue-type plasmin-
ogen activator (tPA) or urokinase plasminogen activator (uPA) to
active plasmin. Plasmin has a critical role in host fibrinolysis and
extracellular matrix remodeling and therefore its activity is tightly
controlled. Binding of plasminogen by mammalian plasminogen
receptors is mediated by lysine-binding Kringle domains [3].
Binding of plasminogen to a mammalian receptor, fibrin clot, or a
bacterial cell facilitates its activation to plasmin and makes the
molecule less susceptible to inactivation by a2 antiplasmin [4,5].
Many bacterial species are able to bind and use host
plasminogen. B. burgdorferi is known to bind host plasminogen,
which can then be converted to active plasmin. B. burgdorferi with
bound plasmin is able to degrade fibronectin, penetrate the
endothelium, and activate matrix metalloprotease-9 (MMP-9) and
MMP-1 [6,7,8]. Plasminogen is required for efficient dissemina-
tion in ticks, and plasminogen deficient mice have decreased
spirochetemia [9]. Several plasminogen-binding proteins have
been identified and characterized in B. burgdorferi, including ErpA/
C/P, OspA, OspC, and a 70 kDa plasminogen binding protein
[10,11,12,13].
Enolases are cytosolic metalloenzymes that catalyze the
conversion of 2-phospho-D-glycerate to phosphoenolpyruvate
[14]. Despite the lack of classical protein sorting machinery or
cell membrane anchoring moieties, enolases are expressed on the
surface of a variety of eukaryotic cells (including neuronal, cancer,
epithelial, endothelial and hematopoietic cells), where they can
function as plasminogen receptors [14]. Remarkably, enolases are
also found on the surface of bacterial cells where they can similarly
function as plasminogen receptors [4,14,15,16].
While several plasminogen-binding proteins have been pro-
posed and partially characterized for B. burgdorferi, we reasoned
that the B. burgdorferi enolase might also be a plasminogen-binding
protein. We now demonstrate that the B. burgdorferi enolase is
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plasminogen.
Materials and Methods
Bacteria
Virulent Borrelia burgdorferi strain B31-MI-16 [17,18,19] was
grown at 34uC to cell densities of approximately 1610
7 ml in
modified Barbour-Stoenner-Kelly II (BSK-II) medium [20]. Total
DNA (chromosomal and plasmids) was isolated using the DNeasy
blood and tissue kit (Qiagen, Valencia, CA) according to the
manufacturer’s instructions.
Recombinant proteins
Polyhistidine-tagged, full-length ErpC has been described
previously [10,21,22]. All recombinant proteins contained ami-
no-terminal tags. The enolase gene (ORF BB0337) plus approx-
imately 500 bp upstream and downstream DNA, was produced by
PCR of B. burgdorferi B31-MI-16 DNA using primers enoF flk 59
tgcttgtgccatgaggaata and enoR flk 59 ataaggcacggcatttcaag and
subsequent cloning into pCR2.1 (Invitrogen, Carlsbad, CA). Full-
length enolase for recombinant protein production was produced
by PCR using primers enoF prot 59caccatgggttttcacatttatgaaatca
and enoR prot 59ttatttttgtttaatagaataaaagacgctc and insertion into
pET200 (Invitrogen). The resultant plasmid’s insert was entirely
sequenced on both strands to ensure that no undesired mutations
had occurred during PCR or cloning procedures. Recombinant
proteins were expressed in Escherichia coli Rosetta (DE3)pLysS
(Novagen, Madison, WI), upon induction with isopropyl-b-D-
thiogalactopyranoside (IPTG). Induced E. coli cells were harvested
and then lysed by two passages through a French pressure cell at
1,000 p.s.i in a mixture of 30 mM imidazole, 0.5 M NaCl, and
20 mM NaPO4 (pH 7.4), and debris was cleared by centrifuga-
tion. Recombinant proteins were purified from cleared lysates
using MagneHis nickel-conjugated magnetic beads (Promega,
Madison, WI). All recombinant proteins were dialyzed overnight
against phosphate-buffered saline (PBS) using 3,500 kDa molec-
ular-weight-cutoff Slide-A-Lyzer cassettes (Pierce, Rockford, IL) at
4uC. Protein purity was assessed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) followed by
staining with Coomassie brilliant blue. Protein concentrations
were determined by bicinchoninic acid protein assays (BCA;
Pierce).
SDS-PAGE and Western blotting
Fresh BSKII medium and spent BSKII medium from late log
phase cultures of B. burgdorferi were centrifuged briefly (12,000 x g,
10 minutes) and the supernatants, recombinant enolase (1.25 mg/
ml) or whole-cell lysate from log-phase B. burgdorferi (2610
7
bacteria/ml) were separated by SDS-PAGE and proteins were
either transferred to nitrocellulose membranes or stained with
Coomassie brilliant blue. Membranes were blocked overnight at
4uC with 5% (w/v) non-fat dried milk in Tris-buffered saline-
Tween 20 (TBS-T; 20 mM Tris (pH7.5), 150 mM NaCl, 0.05%
(v/v) Tween 20). Membranes were next washed with TBS-T, and
incubated for 2 h at room temperature with rabbit antiserum
raised against human a-enolase (Pierce) diluted 1:500 in TBS-T.
After extensive washing with TBS-T, membranes were incubated
for 1 h at room temperature with horseradish-peroxidase-
conjugated donkey anti-rabbit IgG antibody (GE Healthcare,
Piscataway, NJ), diluted 1: 20,000 in TBS-T. After a final series of
washes with TBS-T, bound antibodies were detected using
SuperSignal West Pico enhanced chemiluminescence substrate
(Pierce).
In situ protease analysis
B. burgdorferi were grown to mid-exponential phase in BSK-II,
pelleted by centrifugation, washed once with PBS, and resus-
pended in PBS to a final concentration of approximately 2610
9
bacteria/ml. Examination of bacterial suspensions by darkfield
microscopy did not indicate detectable lysis of the bacteria.
Bacteria were then incubated at room temperature in PBS
containing 40 mg of proteinase K (Fisher Scientific, Pittsburgh, PA)
for 30, 60 or 120 minutes, whereupon digestion was terminated by
addition of paramethylsulfonyl fluoride (PMSF; Sigma) to a final
concentration of 1.6 mg/ml, followed by sample boiling. Control
aliquots of bacteria were incubated in buffer for 2 h at room
temperature without added protease, followed by the addition of
inhibitor and boiling as with the protease-treated bacteria. Equal
volumes of each bacterial lysate were subjected to SDS-PAGE and
transferred to nitrocellulose membranes, and the susceptibility of
enolase to protease digestion was assessed by immunoblot analysis
with rabbit polyclonal anti-human a-enolase (Pierce) as described
above. As experimental controls, lysates were also immunoblotted
with monoclonal antibodies directed against OspC (located on the
bacterial outer surface and thus susceptible to proteolysis [22,23])
and FlaB (located in the periplasmic space and thus protected
against protease digestion in intact bacteria [24]). Densitometric
analysis was performed using ImageJ software (http://imageJ.nih.
gov/ij).
Immunoelectron microscopy
For immunogold localization of enolase and OspC, cultures of
B. burgdorferi were grown to mid-exponential phase then harvested
by centrifugation and washed three times in sterile PBS, pH 7.4.
TEM grids were washed repeatedly in PBS both before processing
and between all incubation steps. All solutions were microfiltered
using 0.4 mm syringe filters prior to use. Fifty microliter droplets
containing non-diluted B. burgdorferi. were placed on the surface of
parafilm covered plastic petri dishes. Gold 400 mesh formvar
coated carbon-stabilized TEM grids (Ted Pella, Redding, CA)
were then placed on each droplet for 90 mins at room
temperature followed by a 20 minute fixation with buffered 4%
paraformaldehyde. Sections were then incubated sequentially in
the appropriate blocking buffer (4% normal serum/PBS, 1 hr. at
room temperature), polyclonal rabbit anti-human a-enolase (1:50
in blocking buffer, Pierce) or monoclonal mouse anti-OspC ([25]
kind gift of Brian Stevenson), for 2 hours followed by biotinylated
goat anti-rabbit or horse anti mouse IgG (1:500 in blocking buffer,
Figure 1. Conservation of enolase. (A) Alignment of enolases from mouse, human, yeast and B. burgdorferi. Dark shaded residues indicate
identity; light gray residues indicate similarity. Arrows indicate the 3 conserved residues that make up the enzymatic active site; stars indicate the
three conserved residues required for binding the cofactor manganese. (B) A rabbit polyclonal antiserum directed against human enolase recognizes
enolase from B. burgdorferi. Top panel: Western blot; Bottom panel: Coomassie-stained SDS-PAGE gel. Molecular weight markers are indicated on the
left. Lane 1: fresh BSKII medium; Lane 2: spent BSKII medium from late-log phase cultures of B. burgdorferi; Lane 3: B. burgdorferi cell lysate; Lane 4:
recombinant enolase from B. burgdorferi.
doi:10.1371/journal.pone.0027502.g001
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was followed by a 30 min incubation on droplets of streptavidin-
conjugated 10 nm gold particles (Ted Pella). Grids were stabilized
by post-fixation on droplets of 4% paraformaldehyde/2%
glutaraldehyde for 10 minutes and washed repeatedly in PBS.
To further assess specificity of the monoclonal anti-enolase
antibody, additional spirochete grids were processed as described
above with omission of the primary antibody. Grids were then
counterstained by placing on droplets of a 5% molybdate solution
for 60 seconds, washed repeatedly in PBS and viewed using a
Hitachi 7500 transmission electron microscope.
ELISA
For the enzyme-linked immunosorbent assay (ELISA), Max-
isorp 96- well plates (Nalge-Nunc, Rochester, NY) were coated
overnight with 10 mg/ml human plasminogen (Sigma-Aldrich, St.
Louis, MO), 10 mg/ml recombinant enolase, 10 mc/ml recombi-
nant ErpC (positive control for plasminogen binding), or 10 mg/ml
bovine serum albumin (BSA [negative control]) in PBS at 4uC.
Plates were brought to room temperature and washed once with
PBS supplemented with 0.05% (vol/vol) Tween 20 (PBS-T). Wells
were blocked for 2 h at room temperature with PBS with 1%
(mass/vol) gelatin and then washed three times with PBS-T.
Afterwards, 100 ml/well of either recombinant enolase, ErpC or
plasminogen (Sigma-Aldrich) [see text for concentrations]) was
added and incubated for 2 h at 37uC. Wells were washed three
times with PBS-T and then incubated for 1 h at room temperature
with rabbit antiserum raised against human a-enolase (which
cross-reacts with the highly similar Borrelia burgdorferi protein;
Pierce), diluted 1:500 in PBS, or goat anti-human plasminogen
(Novus Biologicals, Littleton, CO). Plates were washed three times
with PBS-T, and then wells were incubated for 1 h at room
temperature with horseradish peroxidase-conjugated anti-goat
immunoglobulin G (IgG; Jackson Immunochemicals, West Grove,
PA), horseradish peroxidase-conjugated anti-rabbit IgG (GE
Healthcare), or horseradish peroxidase-conjugated protein G
(Invitrogen), diluted 1:5,000. Wells were again washed three times
with PBS-T, 100 ml/well. Tetramethylbenzidine substrate
(Thermo Scientific, Rockford, IL) was added, and then reactions
were stopped by addition of 100 ml/well of 2 N H2SO4.
Absorbance was read at 450 nm using a BioTek plate reader
utilizing KC4 software (BioTek, Winooski, VT). To determine the
role of lysines in plasminogen-enolase interaction, the lysine analog
e-aminocaproic acid (final concentration, 3–30 mM [Sigma-
Aldrich]) was added with plasminogen to enolase-coated wells.
Protein binding affinities (Kd) were calculated as that concentration
of ligand required for half-maximal binding activity. For
experiments examining the role of ionic interactions in enolase
binding to plasminogen, increasing concentrations of NaCl were
added to the PBS-based binding buffer with enolase. For
experiments analyzing the ability of whole B. burgdorferi to bind
recombinant enolase, plates were coated overnight with intact B.
burgdorferi (2610
7/ml; washed 3X in PBS); after washing and
blocking with SeaBlock (Pierce) for 2 hours, recombinant B.
burgdorferi enolase (0–50 mg/ml) was added for 2 hours at 37uC,
plates washed, and enolase detected as described above.
Figure 2. B. burgdorferi enolase is surface exposed. (A)
Demonstration of outer surface exposure of enolase by in situ protease
degradation. Whole B. burgdorferi were incubated with proteinase K for
30, 60 or 120 minutes or 120 minutes in buffer with no protease.
Proteases were then inactivated, bacteria were lysed, proteins were
separated by SDS-PAGE, and the integrity of enolase, OspC (outer
surface protein), and FlaB (periplasmic protein) were analyzed by
immunoblot. Two separate protease degradation experiments were
performed, with blots repeated 4 times. A representative blot is shown.
(B) Densitometric analysis of in situ protease degradation immunoblots.
Images from blots were scanned and peak areas for 120-minute
proteinase K treatment and no protease control were assessed using
ImageJ software (http://imageJ.nih.gov/ij). Data represent the means
and standard errors from 4 separate blots. *, P=0.03, Student’s t test
assuming unequal variances. (C) Binding of exogenous B. burgdorferi
enolase to the surface of whole bacteria. Binding of B. burgdorferi
enolase (0–50 mg/ml) to immobilized B. burgdorferi (2610
7/ml) was
analyzed by ELISA, with bound enolase detected by rabbit polyclonal
antiserum directed against human enolase. Data represent the means
and standard errors from three separate experiments with six replicates
per enolase concentration.
doi:10.1371/journal.pone.0027502.g002
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Maxisorp 96-well plates (Nalge-Nunc) were coated overnight
with 10 mg/ml recombinant enolase or 10 mg/ml BSA in PBS at
4uC. Plates were brought to room temperature and washed once
with PBS-T. Wells were blocked for 2 h at room temperature with
PBS with 2% (mass/vol) BSA and then washed three times with
PBS-T. Afterwards 100 ml/well of 10 mg/ml human plasminogen
was added and incubated for 2 h at 37uC. Wells were washed three
times with PBS-T, and then 4 ng/well of human uPA (Chemicon,
Temecula, CA) was added. Next, the plasmin-specific substrate D-
valyl-leucyl-lysine-p-nitroanilide dihydrochloride (Sigma-Aldrich)
was added at a final concentration of 0.3 mM in 64 mM Tris,
350 mM NaCl, 0.15% Triton X-100 (pH 7.5). Plates were
incubated overnight at 37uC, and absorbance was read at 405 nm.
Results
B. burgdorferi enolase is surface exposed
Enolases are highly conserved among organisms as diverse as
bacteria and humans [14]. Alignment of enolases from diverse
species suggested that an anti-human antibody might recognize B.
burgdorferi enolase (Figure 1A). Notably, the amino acid residues
required for binding the cofactor, manganese (165E, 206E, 339L),
as well as the residues of the enzymatic active site (243D, 289E,
317D), were also conserved (Figure 1A and [27]). Recombinant B.
burgdorferi enolase or whole cell lysate were separated by SDS-
PAGE and transferred to nitrocellulose. As anticipated, an anti-
human a-enolase polyclonal antibody recognized purified recom-
binant B. burgdorferi enolase as well as the native enolase in whole
cell lysates (Figure 1B). Since the B. burgdorferi medium is rich in
bovine serum albumin and rabbit serum, we confirmed that the
medium itself was not recognized by the anti-human a-enolase
antibody (Figure 1B, fresh BSK-II lane).
Despite the lack of canonical protein export sequences, enolases
of many species, both bacteria and eukaryote, are localized on the
cell surface [14,16,27,28,29,30,31,32,33,34,35]. The B. burgdorferi
enolase was previously shown to fractionate with both the soluble
and membrane fractions [36]. To address the possibility of surface
exposure of enolase, in situ protease degradation assays were
performed. Intact B. burgdorferi were incubated in the presence of
Figure 3. Immunoelectron microscopic analysis of B. burgdorferi
enolase. A) Anti-enolase was localized intermittently across the outer
surface of B. burgdorferi (arrows). Gold particles were also observed on
membrane blebs in proximity to the spirochete (asterisks). The boxed
area in the inset indicates the region demonstrated in image (A). B)
Omission of the primary antibody resulted in a complete loss of
immunoreactivity. C) Anti-OspC immunolabeling demonstrated mod-
erately heavy labeling on the outer surface of the spirochete (Arrows).
Magnification bar =0.2 mm.
doi:10.1371/journal.pone.0027502.g003
Figure 4. B. burgdorferi enolase binds plasminogen. (A) Binding of
plasminogen (25 mg/ml) to immobilized proteins (10 mg/ml) was
analyzed by ELISA, with bound plasminogen detected using specific
antiserum. BSA was used as a negative control for nonspecific binding.
ErpC is a known plasminogen binding protein of B. burgdorferi [10].
Data represent the means and standard errors from three separate
experiments with six replicates per protein. ***, P,0.001, Student’s t
test assuming unequal variances. (B) Enolase binds plasminogen in a
dose-dependent manner. Binding of plasminogen (10 mg/ml) to
immobilized enolase (0–1 mM) was analyzed by ELISA, with bound
plasminogen detected using specific antiserum. BSA was used as a
negative control for nonspecific binding. Values represent plasminogen
binding to enolase minus background absorbance for BSA. Data
represent the means and standard errors from a representative
experiment (1 of 4) with six replicates per concentration of enolase.
doi:10.1371/journal.pone.0027502.g004
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inactivated, bacteria were lysed and proteins separated by SDS-
PAGE. After transfer to nitrocellulose membranes, blots were
incubated with antisera specific for OspC, an outer surface
protein, FlaB, a periplasmic protein, or enolase. As shown in
Figure 2A, OspC was totally degraded, indicating surface
exposure. FlaB was not affected by the protease, indicating that
the bacteria were intact. There was a considerable reduction in the
amount of enolase detected by 120 minutes of incubation with
proteinase K, compared to the no protease control. Densitometric
analysis of band intensities revealed a significant reduction in peak
area between the 120-minute proteinase K treated band and the
no protease control (Figure 2B). Although enolase is a glycolytic
enzyme, and found within the cytoplasm, these data indicate that a
proportion of B. burgdorferi enolase is also surface exposed.
In Gram-positive bacteria such as Streptococcus pneumoniae, it has
been suggested that autolysins are involved in liberating enolase
from the bacterial cytoplasm, and that streptococci scavenge
enolase from lysed neighbor cells [37,38]. However, we were
unable to detect enolase in spent culture medium from late log
phase B. burgdorferi (Figure 1B, spent BSKII lane). In addition, we
incubated intact B. burgdorferi (2610
7 bacteria/ml) with recombi-
nant B. burgdorferi enolase and assayed the amount of surface-
associated enolase by ELISA. We did not detect any significant
increase in surface-bound enolase compared to bacteria incubated
in the absence of exogenous B. burgdorferi enolase (Figure 2C).
We then used immunoelectron microscopy to confirm the
presence of enolase on the spirochete outer membrane. Our analysis
revealed that gold-labeled anti-human a-enolase was scattered
sporadically over the outer surface of the majority of spirochetes
(Figure 3A). The density of labeling was quite variable cell-to-cell
suggesting some variability in surface exposure of enolase among
individual spirochetes. It is noteworthy that labeling was routinely
observed on isolated patches of material resembling outer membrane
(Figure 3A. asterisks). Omission of the anti-enolase antibody resulted
in thecompleteabsenceofgoldlabelingonallcontrolgridsexamined
(Figure 3B). Antibody against an abundant outer surface protein,
OspC, was used as a positive control. Anti-OspC labeling was
generally denser than enolase, and tended to localize in large patches
covering the surface of the spirochete (Figure 3C). The dense labeling
of OspC is consistent with the presence of a well-preserved outer
membrane and supports our data indicating the localization of
enolase to the outer surface of B. burgdorferi.
Enolase binds human plasminogen
Previous studies have demonstrated that enolases of various
gram-positive and gram-negative bacteria bind plasminogen
(reviewed in [4]), and this prompted us to investigate whether
the enolase of B. burgdorferi was capable of binding human
plasminogen. Microtiter plates were coated with recombinant
enolase, bovine serum albumin (negative control protein) or ErpC
(a known B. burgdorferi plasminogen-binding protein [10]), and then
plasminogen binding was assayed by ELISA. Enolase demonstrat-
ed significant binding of human plasminogen (Figure 4A). Analyses
using various concentrations of recombinant enolase demonstrated
that B. burgdorferi enolase bound plasminogen in a dose-dependent
manner, with an apparent Kd of 125 nM (Figure 4B).
Role of lysines in enolase-plasminogen binding
Plasminogen receptors, both mammalian and bacterial, often
bind plasminogen through lysine residues that interact with the
Kringle domains of plasminogen [14,39,40,41]. The enolase of B.
burgdorferi is comprised of 5.7% lysine residues. Addition of the
lysine analog e-aminocaproic acid significantly reduced the
interaction between enolase and plasminogen, while the lysine
analog had no effect on the background binding of plasminogen to
BSA (Figure 5). These data indicate a role for lysines in enolase-
plasminogen binding.
Role of ionic interactions in enolase-plasminogen
binding
The enolase of B. burgdorferi is highly charged, with a theoretical
pI of 5.38. To assess the role of ionic interactions in enolase
Figure 5. Role of lysines in enolase/plasminogen binding
activity. Binding of plasminogen to immobilized enolase (10 mg/ml)
was analyzed by ELISA. Plasminogen (25 mg/ml) was added to enolase-
coated wells in the presence or absence of 0–30 mM e-aminocaproic
acid (lysine analog). Bound plasminogen was detected using a specific
antiserum. BSA was used as a negative control. Data represent the
means and standard errors from three separate experiments with 12
replicates per condition. ***, P,0.001, Student’s t test assuming
unequal variances.
doi:10.1371/journal.pone.0027502.g005
Figure 6. Role of ionic interactions in enolase binding of
plasminogen. Binding of plasminogen to immobilized enolase (10 mg/
ml) was analyzed by ELISA. Plasminogen (25 mg/ml) was incubated in
the presence of increasing concentrations of NaCl. Bound plasminogen
was detected using a specific antiserum. BSA was used as a negative
control. Data are presented as % control (physiological NaCl, 150 mM)
from the means and standard errors from three experiments with six
replicates per concentration of NaCl.
doi:10.1371/journal.pone.0027502.g006
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presence of various concentrations of NaCl. NaCl at up to four
times the normal physiological concentration had a small but
insignificant negative effect on binding (Figure 6). These data
suggest that ionic interactions are not required for the enolase-
plasminogen interaction.
Plasminogen bound to enolase can be converted to
active plasmin
B. burgdorferi-bound plasminogen is converted to plasmin [11].
To determine if enolase-bound plasminogen can also be converted
to the active enzyme, microtiter plates were coated with enolase,
blocked, plasminogen and the activator uPA were added, and
proteolytic activity was quantified using a plasmin-specific
chromogenic substrate. As shown in Figure 7, enolase-bound
plasminogen was converted to active plasmin. These data suggest
that, in vivo, enolase-bound plasminogen would be accessible to
plasminogen activators.
Discussion
Enolases belong to a class of proteins referred to as
moonlighting proteins: proteins that have multiple functions and
often exist in distinct locations within a cell [42]. Along with its
role as an essential glycolytic enzyme, we have demonstrated that
B. burgdorferi enolase has an additional function as a cell-surface
plasminogen receptor. Enolases lack traditional sorting signals and
how these proteins become surface exposed is unknown. The
enolase of B. burgdorferi is both cytoplasmic and surface exposed
(Figures 2 and 3, and [36]), and humans and animals produce
antibodies to the B. burgdorferi enolase during natural infection [43].
Proteins destined for the outer surface are expensive for a cell to
produce [44], and the amino acid sequence of enolase certainly
suggests an inexpensive protein. The B. burgdorferi protein, like
many enolases, is rich in ‘‘cheap’’ amino acids such as alanine
(8.3%) and glycine (7.2%) while low in ‘expensive’ amino acids
such as phenylalanine (3.9%) and tryptophan (1.3%). Intriguingly,
a hydrophobic domain in human aenolase suggested to play a role
in its membrane association (AAVPSGASTGI) is identical in the
B. burgdorferi enolase [14]. It is clear, however, that for both
eukaryotic and bacterial enolases, surface exposure is not unusual
[16,27,28,29,30,32,33,34,35,45]. Other cytoplasmic proteins, such
as DnaK, have also been identified as plasminogen-binding
proteins [46,47].
A potential consequence of the surface exposure of the B.
burgdorferi enolase is its possible contribution to autoimmunity.
Streptococcal enolases are cross-reactive with human enolase and
are thought to play a role in post-streptococcal sequelae such as
rheumatic heart disease [48]. Eukaryotic enolases are also
associated with autoimmune conditions. The identified cross-
reactive epitopes in cancer-associated retinopathy (FRAAVPSG
and RYMGKGVS) are almost identical to the residues present in
the B. burgdorferi enolase [49].
Lysine residues play a critical role in the interaction of
plasminogen receptors with their ligand. A number of bacterial
plasminogen-binding proteins contain essential lysines [4,6,10,50].
The lysine analog e-aminocaproic acid significantly inhibited
enolase binding to plasminogen. For many plasminogen receptors,
it is the C-terminal lysines that are critical for binding [16,39]. The
lysine residues in B. burgdorferi enolase, however, are dispersed.
Internal plasminogen binding sites have been identified for other
pathogen’s receptors [51,52,53]. We are continuing to define the
plasminogen-binding site(s) of the B. burgdorferi enolase.
Plasminogen binding by B. burgdorferi is clearly important in vivo.
Plasminogen-deficient mice exhibit reduced spirochetemia, and
plasminogen is required for efficient dissemination of B. burgdorferi
within the tick vector [9]. B. burgdorferi-bound plasminogen can
degrade extracellular matrix proteins and activate matrix
Figure 7. Enolase-bound plasminogen is converted into plasmin. Enolase-coated wells of microtiter plates were incubated with
plasminogen, urokinase (uPA), and/or a plasmin-specific chromogenic substrate. Proteolytic activity was measured by absorbance at 405 nM. Data
represent the means and standard errors from three different experiments with six replicates per condition. ***, P,0.001 compared to the activation
of plasminogen bound to the control protein, BSA, Student’s t test assuming unequal variances.
doi:10.1371/journal.pone.0027502.g007
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tissues [6,7,8]. Interestingly, B. burgdorferi upregulates expression of
both the plasminogen activator uPA and the plasmin inhibitor
PAI-2 from monocytes. The upregulation of uPA could activate
plasminogen bound to the surface of B. burgdorferi. The upregula-
tion of PAI-2 had no effect on B. burgdorferi transmigration but did
decrease monocyte migration across Matrigel [54]. In addition to
the suppression of leukocyte function, B. burgdorferi may capitalize
on plasminogen binding for other immune evasive strategies. For
instance, binding of plasminogen is anti-opsonic for Staphylococcus
aureus, and the enolase of Streptococcus sobrinus increases IL-10
expression in mice [55,56].
It is not surprising that B. burgdorferi may express multiple
plasminogen-binding proteins on its surface [10,11,12,13]. Re-
dundancy in bacterial adhesins is not unusual. Indeed, B. burgdorferi
possesses at least three distinct fibronectin-binding proteins
[57,58,59]. Many bacterial pathogens possess both high and
low-affinity plasminogen-binding proteins on their cell surface
[60,61]. The B. burgdorferi plasminogen-binding protein ErpP, for
instance, has a Kd of ,25 nM, while we calculate that the enolase
has a Kd of ,125 nM (Figure 4B, and [10]. In addition, B.
burgdorferi may utilize different plasminogen-binding receptors at
different stages in its infectious life cycle, i.e., tick versus mammal.
Plasminogen binding may not be the only function of extracellular
enolase; the enolase of S. aureus binds laminin, and LenA, a surface
receptor of Leptospira interrogans, interacts with plasminogen,
complement Factor H, and laminin [26,31,62]. The plasmino-
gen-binding OspA protein of B. burgdorferi also functions in
invasion of the tick salivary glands, and ErpP of B. burgdorferi
binds both plasminogen and complement factor H [10,63].
B. burgdorferi is a successful extracellular pathogen that co-opts
host proteins for its own advantage. We have identified that the
enolase of B. burgdorferi moonlights as a surface-exposed,
plasminogen-binding protein.
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